Gilead Sciences has picked up a new inflammatory disease program from China’s PepStar Therapeutics to pair with the Phase 2 inflammatory bowel disease asset emvistegrast.
Gilead shops in IL-23, inking $1.3B upfront I&I deal with China’s PepStar Read More »
Following the withdrawal of billions of dollars in investments from Boehringer Ingelheim and Eli Lilly, German lawmakers have proposed a clause to the country’s healthcare reforms set to take effect Jan. 1.
EQT Private Equity has agreed to pay about $12.1 billion, including debt, for the diagnostics company, which has long been the subject of takeover speculation.
After cardiac safety signals led to a full clinical hold on Aardvark Therapeutics’ studies of ARD-101, the biotech conducted an additional safety study, in which no cardiac events were detected. Aardvark plans to resume testing the candidate next year.
FDA uncages Aardvark’s Prader-Willi study after new data cleared safety concerns Read More »
A new proposal from the U.S. government seeking to address investment in Chinese biotech as a matter of national security drew cautious statements from across the industry, with leaders vowing to ensure innovation isn’t stifled.
US explores China biotech restrictions, exempts licensing deals Read More »
Invikafusp alfa, a first-in-class dual T cell agonist, showed an objective response in various types of cancer, particularly among patients who did not respond to previous checkpoint inhibitor therapy.
ESMO 2026: Marengo’s bispecific antibody shrinks 8 tumor types in Phase 2 Read More »
Roche will pay Zymeworks $55 million upfront plus another $40 million once the partnership asset enters Phase 1b development and up to $718 million in additional milestones.
Roche bets up to $813M on Zymeworks’ lung cancer trispecific T cell engager Read More »
La ciencia del sueño avanza a pasos agigantados, revelando conexiones invisibles pero letales entre cómo respiramos por la noche y cómo late nuestro corazón durante el día. Entre los trastornos más estudiados destaca la apnea obstructiva del sueño (AO …
¿El ronquido esconde un peligro para tu corazón? Read More »
Durante miles de millones de años, la Tierra estuvo dominada exclusivamente por microorganismos unicelulares simples: bacterias y arqueas carentes de núcleo definido. Sin embargo, en algún momento de este vasto pasado, un salto evolutivo sin precedentes dio origen a las cé …
Imaginemos estar en alta mar en el año 1906. Una tormenta feroz azota el barco, el agua comienza a inundar la sala de máquinas y el capitán da la orden de evacuar. A bordo hay un nuevo y revolucionario aparato: la telegrafía sin hilos de Marconi. El operador de radio se s …
